New Delhi, 6 June 2024: Widely used life-saving antibiotic Meropenem manufactured by Pfizer and other leading pharmaceuticals firms, can have adverse reactions, the Union government’s Indian Pharmacopoeia Commission (IPC) has found, and advised doctors and patients to be ca......
View Details

Related News

• Indian Patent Office to hear objections on Gilead's HIV drug patent claims (18-09-2024)

---

• CDSCO revises guidance document for functions & responsibilities of zonal, sub-zonal & port offices (18-09-2024)

---

• India exported drugs and pharma worth $11.9 bn in April-August 2024 (18-09-2024)

---

• US FDA releases draft guidance on oncology multiregional clinical trials (18-09-2024)

---

• Narcotists raid in UP-Uttarakhand, fake medicines worth three crores, machines worth eight crores seized, five arrested (18-09-2024)

---

• DCC recommends making Sugam portal database of all products with brand names (17-09-2024)

---

• CDSCO releases draft guidelines on good clinical practices for consultation (17-09-2024)

---

• One-third of India’s 30 lakh sepsis deaths linked to antimicrobial resistance (17-09-2024)

---

• Pharmacist practicing without degree, 35 types of medicines and surgical equipments seized (17-09-2024)

---

• CDSCO to switch Form 44 submission online (16-09-2024)

---